Regulatory T cell Function in Pediatric Lung Injury

小儿肺损伤中的调节性 T 细胞功能

基本信息

  • 批准号:
    8782734
  • 负责人:
  • 金额:
    $ 5.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall objective of this NRSA Individual Fellowship is to develop skills that will allow the candidate to become a physician-scientist and pursue an academic research career. The applicant and his mentors have devised a training approach that includes both research and didactic instruction. This approach will establish the knowledge and intellectual framework essential for a successful research career. The proposal concerns acute lung injury (ALI) in neonates and juveniles. Pediatric acute lung injury represents a major global source of morbidity and mortality. Pneumonia-associated ALI in neonates accounts for 10% of annual childhood deaths. Despite the healthcare burden associated with this disease, the mechanisms through which pediatric ALI resolves remain unknown. Regulatory T cells (Tregs), a subset of cells in the adaptive immune system that suppresses exuberant immune responses, have been shown to play a critical role in lung injury resolution in an adult mouse endotoxin (LPS) model of ALI. There is, however, little data on the role and function of Tregs in pediatric ALI. Tregs play an important role in fetal life by suppressing auto-reactive immune cells and preventing inflammation that may lead to fetal loss; however, these cells may be functionally impaired in the newborn as the immune system transitions from a tolerant state to a pro-inflammatory one. The candidate has preliminary data showing in neonates, unlike in juvenile mice, alveolar Treg numbers do not increase following LPS- mediated lung injury. Increasing Treg number by adoptive transfer enhances resolution and restores normal growth and development in LPS-injured neonates. The focus of this proposal is to further examine the factors that contribute to the diminished Treg response in neonates with the long term hope of discovering novel therapeutic targets for children with ALI. In Specific Aim 1, the candidate will examine the differences in the Treg response of neonatal and juvenile mice following lung injury. Multicolor flow cytometry will be used to determine Treg kinetics and phenotype. Adoptive Transfer of neonatal Tregs into Treg-depleted adults and suppression assays will measure in vivo and ex vivo Treg function. Specific Aim 2 will define the IL-2/CD25 axis modulation of the neonatal Treg response. The candidate will determine age-dependent IL-2 expression by real time PCR and ELISA. He will also define the ability of exogenous IL-2 administration to expand Treg numbers, increase suppressive function, and enhance acute lung injury resolution. These experiments will explore the mechanisms controlling neonatal Treg function following acute lung injury with the ultimate hope of improving patient outcomes in this lethal disease.
描述(由申请人提供):该NRSA个人奖学金的总体目标是发展技能,使候选人成为医师科学家并从事学术研究职业。申请人及其导师设计了一种培训方法,其中包括研究和教学教学。这种方法将建立成功研究职业必不可少的知识和知识框架。该提案涉及新生儿和少年的急性肺损伤(ALI)。小儿急性肺损伤代表了全球发病率和死亡率的主要来源。肺炎与新生儿相关的ALI占儿童死亡人数的10%。尽管与这种疾病相关的医疗保健负担,但小儿阿里解决的机制仍然未知。 调节性T细胞(Tregs)是抑制繁殖免疫反应的自适应免疫系统中细胞的子集,已显示在ALI的成年小鼠内毒素(LPS)模型中起关键作用。但是,关于Treg在小儿ALI中的作用和功能的数据很少。 Tregs通过抑制自身反应性免疫细胞并防止炎症可能导致胎儿丧失,在胎儿生活中发挥重要作用。但是,这些细胞在新生儿的功能上可能会受到损害,因为免疫系统从耐受状态转变为促炎性状态。该候选人在新生儿中显示了初步数据,与少年小鼠不同,LPS介导的肺损伤后肺泡数量不会增加。通过收养转移增加TREG数量可以增强分辨率,并恢复LPS损害的新生儿的正常生长和发展。该提案的重点是进一步研究新生儿中Treg反应减少的因素,长期希望为ALI儿童发现新的治疗靶点。 在特定的目标1中,候选人将检查肺损伤后新生儿和少年小鼠的Treg反应的差异。多色流式细胞仪将用于确定Treg动力学和表型。新生儿Tregs的收养转移到贫困的成年人中,抑制测定将测量体内和离体Treg功能。特定的目标2将定义新生儿Treg响应的IL-2/CD25轴调节。候选人将通过实时PCR和ELISA确定年龄依赖性的IL-2表达。他还将定义外源性IL-2给药扩大TREG数量,增加抑制功能并增强急性肺损伤的能力。这些实验将探索急性肺损伤后控制新生儿Treg功能的机制,并最终希望改善这种致命疾病的患者结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin Gibbs其他文献

Kevin Gibbs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
  • 批准号:
    82302445
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
  • 批准号:
    82374400
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
  • 批准号:
    82374186
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
  • 批准号:
    10658610
  • 财政年份:
    2023
  • 资助金额:
    $ 5.89万
  • 项目类别:
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators
多物质暴露后的肺功能障碍:炎症介质的机制识别
  • 批准号:
    10662187
  • 财政年份:
    2022
  • 资助金额:
    $ 5.89万
  • 项目类别:
Testing the feasibility and acceptability of social media and digital therapeutics to decrease vaping behaviors
测试社交媒体和数字疗法减少电子烟行为的可行性和可接受性
  • 批准号:
    10671544
  • 财政年份:
    2022
  • 资助金额:
    $ 5.89万
  • 项目类别:
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital
针对儿科医院青少年和年轻人制定和实施烟草和电子尼古丁传送系统使用干预措施
  • 批准号:
    10621209
  • 财政年份:
    2022
  • 资助金额:
    $ 5.89万
  • 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
  • 批准号:
    10594499
  • 财政年份:
    2022
  • 资助金额:
    $ 5.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了